FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - Immunization, Realm US

19,481 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 13200 - 13400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-AdmissionMethodUK Core Admission Methodactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-DischargeMethodUK Core Discharge Methodactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-OutcomeOfAttendanceUK Core Outcome Of Attendanceactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-EncounterLocationTypeUK Core Encounter Location Typeactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-ListCodeUK Core List Codeactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-ListEmptyReasonCodeUK Core List Empty Reason Codeactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-ListWarningCodeUK Core List Warning Codeactive2022-12hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-NHSNumberUnavailableReasonUK Core NHS Number Unavailable Reasonactive2024-06hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-ReasonImmunizationNotAdministeredUK Core Reason Immunization Not Administeredactive2022-08hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-ResidentialStatusUK Core Residential Statusactive2021-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-ProblemSignificanceUK Core Problem Significanceretired2023-04hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-SourceOfAdmissionUK Core Source Of Admissionactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-AddressKeyTypeUK Core Address Key Typeactive2021-09hl7
fhir.r4.nhsengland.stu1R4ValueSet/England-ChildProtectionPlanEngland Child Protection Planactive2023-11hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-DeathNotificationStatusUK Core Death Notification Statusactive2021-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-MedicationSupplyTypeUK Core Medication Supply Typeactive2021-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-MessageEventUK Core Message Eventretired2024-02hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-MedicationPrescribingOrganizationUK Core Medication Prescribing Organizationretired2022-08hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-MedicationPrescribingOrganizationTypeUK Core Medication Prescribing Organization Typeactive2022-08hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-PersonRelationshipTypeUK Core Person Relationship Typeactive2021-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-DischargeDestinationUK Core Discharge Destinationactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-RecordingSettingUK Core Recording Settingactive2023-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-CareSettingTypeUK Core Care Setting Typeactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-DocumentTypeUK Core Document Typeactive2022-12hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-EncounterTypeUK Core Encounter Typeactive2022-01hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-underlying-uncategorized-condition-value-setCOVID-19 uncategorized underlying condition reference setactive2022-07hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-AllergyManifestationUK Core Allergy Manifestationactive2022-08hl7
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4ValueSet/communicationModeVSCommunicationModedraft2022-11hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-EmergencyCareDischargeStatusUK Core Emergency Care Discharge Statusactive2022-01hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-SubstanceOrProductAdministrationRouteUK Core Substance Or Product Administration Routeactive2021-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-SourceOfServiceRequestUK Core Source Of Service Requestactive2025-03hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-underlying-respiratory-condition-value-setCOVID-19 respiratory underlying condition reference setactive2022-07hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-underlying-cardiovascular-condition-value-setCOVID-19 cardiovascular underlying condition reference setactive2022-07hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-underlying-neurolgic-condition-value-setCOVID-19 neurologic underlying condition reference setactive2022-07hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-underlying-gastrointestinal-hepatic-condition-value-setCOVID-19 gastrointestinal or hepatic underlying condition reference setactive2022-07hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid91-underlying-hemoglobinopathy-condition-value-setCOVID-19 hemoglobinopathy underlying condition reference setactive2022-07hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-underlying-immunocompromised-condition-value-setCOVID-19 immunocompromised underlying condition reference setactive2022-07hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-underlying-immune-condition-value-setCOVID-19 immune underlying condition reference setactive2022-07hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-underlying-metabolic-condition-value-setCOVID-19 metabolic underlying condition reference setactive2022-07hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-underlying-renal-condition-value-setCOVID-19 renal underlying condition reference setactive2022-07hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-react-nonreact-borderline-inv-value-setReactive, Non-reactive, Borderline, Invalid value setactive2022-07hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-NHSNumberVerificationStatusUK Core NHS Number Verification Statusactive2022-08hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-VaccinationProcedureSupplementaryUK Core Vaccination Procedure Supplementaryactive2023-12hl7
hl7.fhir.us.vrdrR4ValueSet/vrdr-death-pregnancy-status-vsDeath Pregnancy Status ValueSetactivepher2024-10hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-MedicationAdministrationCategoryUK Core Medication Administration Categoryactive2022-12hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-MedicationRequestCategoryUK Core Medication Request Categoryactive2024-07hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-MedicationStatementCategoryUK Core Medication Statement Categoryactive2022-12hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-MedicationRequestCourseOfTherapyUK Core Medication Request Course Of Therapyactive2021-09hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-SpecimenBodySiteUK Core Specimen Body Siteactive2025-03hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-SpecimenTypeUK Core Specimen Typeactive2025-03hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-BiopsyStateUK Core Biopsy Stateretired2023-10hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-BloodGlucoseUK Core Blood Glucoseactive2025-03hl7
fhir.r4.wales.testR4ValueSet/DataStandardsWales-PatientRecordTypeData Standards Wales Patient Record Typedraft2024-05hl7
fhir.r4.ukcore.stu3.currentbuildR4ValueSet/UKCore-SampleStateUK Core Sample Stateactive2024-10hl7
hl7.fhir.us.vr-common-libraryR4ValueSet/ValueSet-partial-date-data-absent-reason-vrValue Set - Partial Date/DateTime Data Absent Reason Vital Recordsactivepher2025-05hl7
hl7.fhir.us.vr-common-libraryR4ValueSet/ValueSet-yes-no-not-applicable-vrValue Set - Yes No Not Applicable Vital Recordsactivepher2025-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7907Ethnicity (ARLN)active2019-01
hl7.fhir.us.immdsR4ValueSet/ForecastStatusForecast Statusactive2021-06hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-pos-neg-inv-incl-vsCOVID19 Positive, Negative, Invalid, Inconclusive value setactive2022-07hl7
hl7.fhir.us.immdsR4ValueSet/StatusReasonEvaluation Status Reasonactive2021-06hl7
hl7.fhir.us.immdsR4ValueSet/ForecastReasonForecast Reasonactive2021-06hl7
fhir.r4.wales.testR4ValueSet/DataStandardsWales-WrrsTaskTypeData Standards Wales WRRS Task Typedraft2023-05hl7
fhir.r4.wales.discoveryR4ValueSet/DataStandardsWales-VaccinationProcedureVaccination Proceduredraft2023-04hl7
hl7.fhir.us.covid19libraryR4ValueSet/covid19-cvx-codes-value-setCOVID 19 CVX Code System Vaccine Codesactive2022-07hl7
hl7.fhir.us.immdsR4ValueSet/targetDiseaseVaccine Target Diseaseactive2021-06hl7
hl7.fhir.us.breastcancerR3ValueSet/shr-core-PerformanceGradingScaleVSBC PerformanceGradingScaleVS ValueSetdraft2018-08hl7
hl7.fhir.us.physical-activityR4ValueSet/pa-diagnosticreport-categoryPA ServiceRequest Category - USCoretrial-use2pc2024-03hl7
hl7.fhir.us.vrdrR4ValueSet/vrdr-edit-bypass-01-vsEdit Bypass 01activepher2024-10hl7
hl7.fhir.us.vr-common-libraryR4ValueSet/valueset-edit-bypass-01234-vrValue Set - Edit Bypass 01234 Vital Recordsactivepher2025-05hl7
hl7.fhir.us.vrdrR4ValueSet/vrdr-edit-bypass-0124-vsEdit Bypass 0124activepher2024-10hl7
hl7.fhir.us.vrdrR4ValueSet/vrdr-edit-bypass-012-vsEdit Bypass 012activepher2024-10hl7
fhir.r4.wales.discoveryR4ValueSet/DataStandardsWales-MainSpecialtyData Standards Wales Main Specialtydraft2020-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.918Admission Source (HL7)active2019-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.12199LanguageAbilityProficiencyactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.12249LanguageAbilityModeactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7913Candida auris PCR result (ARLN)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.11.20.9.49Residence and Accommodation Typeactive2014-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.88.12.80.68Problem Statusactive2014-12
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.61Care Modelactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.19185Religious Affiliationactive2024-06hl7
fhir.r4.wales.discoveryR4ValueSet/DataStandardsWales-HospitalClassificationData Standards Hospital Classificationdraft2020-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7909Identifier type (ARLN)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7920Interpretation codes (ARLN)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7270Lab Test Result Interpretation (NND)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7904Program study or event (ARLN)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7914Acinetobacter culture result (ARLN)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7912Candida auris culture result (ARLN)active2019-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.7.1SupportedFileFormatsactive2024-06hl7
hl7.fhir.us.splR5ValueSet/valueset-AllNDCProductsAll NDC Productstrial-use1brr2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7924Mother Infant Indicator (NND)active2019-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.1Pregnancy Statusactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.10Pap Smear Testsactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.11HIV Testsactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.12Human Papilloma Virus Testsactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.13Chlamydia Trachomatis Testsactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.14Neisseria Gonorrhoeae Testsactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.17Contraceptive Typeactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.18Contraception Not Used Reasonactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.209Yes and No Answersactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.21Contraceptive Provision Methodactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.210Pap Smear Resultsactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.211Contraceptive discussionactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.24Clinical Provider Roleactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.29Insurance Coverage Typeactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.3Organism Detectionactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1166.31English Proficiencyactive2023-07hl7
hl7.fhir.us.vitalsR4ValueSet/LowOnlyNumericResultIntVSLow Only Numeric Result Interpretation value setdraft2024-10hl7
hl7.fhir.us.registry-protocolsR4ValueSet/LesionComplexityComplexity of the Lesionactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CABGIndicationCABG Indicationactivecic2023-11hl7
hl7.fhir.us.medmorphR4ValueSet/us-ph-computable-valueset-exampleUS Public Health Computable ValueSet Exampledraft2022-07hl7
hl7.fhir.us.ecrR4ValueSet/us-ph-computable-valueset-exampleUS Public Health Computable ValueSet Exampledraft2022-05hl7
hl7.fhir.us.ph-libraryR4ValueSet/us-ph-valueset-computable-exampleUS Public Health ValueSet - Computable Exampledraft2022-07hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1562-laterality-from-landmarkRDE1562 Laterality from landmarkdraft2022-10hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1565-typeRDE1565 Typedraft2022-10hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1568-distributionRDE1568 Distributiondraft2022-12hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1571-associated-featuresRDE1571 Associated featuresdraft2022-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1576-shapeRDE1576 Shapedraft2022-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1577-typeRDE1577 Typedraft2022-10hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1578-densityRDE1578 Densitydraft2022-10hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1579-marginRDE1579 Margindraft2022-10hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1580-orientationRDE1580 Orientationdraft2022-10hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1586-assessment-categoryRDE1586 Assessment categorydraft2022-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1587-breast-composition-categoryRDE1587 Breast composition categorydraft2022-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1588-breast-lateralityRDE1588 Breast lateralitydraft2022-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1589-implant-presenceRDE1589 Implant presencedraft2022-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1590-prior-mastectomyRDE1590 Prior mastectomydraft2022-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/rde1602-typeRDE1602 Typedraft2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1096Rash Syndrome (BT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1089Botulism-like Syndrome (BT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1099Specific Infection Syndrome (BT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1091Gastrointestinal Syndrome (BT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1097Respiratory Syndrome (BT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1095Neurological Syndrome (BT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1098Severe Illness Or Death Syndrome (BT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1090Fever Syndrome (BT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1094Lymphadenitis Syndrome (BT)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7702ATI Method (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3343Abnormal Flag (HL7 27)active2010-01
hl7.fhir.us.breast-radiologyR4ValueSet/rde1556-presenceRDE1556 Presencedraft2022-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.34AbnormalityOfGaitAndMobilityactive2021-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3344Accept Application Acknowledgment Conditions (HL7)active2017-01
hl7.fhir.us.mcodeR4ValueSet/mcode-tumor-size-units-vsTumor Size Units Value Setactive3cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.958Acknowledgment Code (HL7)active2008-01
signal.core.r4R4ValueSet/questionnaire-ccars-action-typesQuestionnaire CCARS Action Typesdraft1pahl7
fhir.cqf.commonR4ValueSet/active-conditionCQF Active Conditionactive2019-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8014Activity Type Anthraxactive2020-01
hl7.fhir.us.vrdrR4ValueSet/vrdr-activity-at-time-of-death-vsActivity at Time of Death ValueSetactivepher2024-10hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3102Skin Exposure Activity (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8011Activity Type (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7985Actual Route of Administration (Anthrax)active2020-01
hl7.fhir.us.nhsn-dqmR4ValueSet/ach-encounter-classAcute Care Hospital Encounter Class ValueSettrial-use1pher2025-07hl7
hl7.fhir.us.nhsn-dqmR4ValueSet/ach-encounter-statusAcute Care Hospital Encounter Status ValueSettrial-use1pher2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3213Signs and Symptoms (Acute Hepatitis B)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3206Lab Test Result Name (Acute Hepatitis B)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3221Disease Type (Acute Hepatitis B)active2009-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.10416Financially Responsible Party Type Value Setactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.20Telecom Use (US Realm Header)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.19579Family Member Valueactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.38Smoking Statusactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3162Risk Factors (TB)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.801Address Type (HL7)active2018-01
hl7.fhir.us.davinci-crdR4ValueSet/locationAddressTypeCRD Location Address Types Value Settrial-use4fm2025-08hl7
hl7.fhir.us.davinci-hrexR4ValueSet/hrex-coverage-relationshipHRex Coverage Relationship ValueSetdraft0cic2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.313Statin Allergen Groupingactive2024-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.1.11.1Administrative Gender (HL7 V3)active2019-01
fhir.kisumuhieR4ValueSet/gender-vsGenderdraft2025-06hl7
fhir.kenyaPSIGR4ValueSet/administrative-gender-vsAdministrative Genderactive2025-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.645Pneumococcal Vaccine HD_CN_ Allergyactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.638b.well Adult Tetanus Vaccine CNactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.648bwell COVID Vaccine CN_Metactive2025-04hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7758Adverse Event Severity (TB)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.963Consequence of Adverse Eventactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7596Adverse Event Severity (Malaria)active2019-01
hl7.fhir.us.registry-protocolsR4ValueSet/YesNoYes or Noactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3065Age Category (Animal)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3259Age Group (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7905Age units (ARLN)active2019-01
hl7.fhir.us.davinci-pdexR4ValueSet/ProvenanceAgentTypeProvenance Agent Typeinformativefm2025-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8054Alanine aminotransferase (ALT) Result (Hepatitis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8019Alcohol Use Frequency (Anthrax)active2020-01
hl7.fhir.us.registry-protocolsR4ValueSet/StressTestCath PCI Selected Stress Testactivecic2023-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/barbiturate-medicationsBarbiturate Medicationsactive2025-02hl7
fhir.cdc.opioid-cds-r4R4ValueSet/buprenorphine-and-methadone-medicationsBuprenorphine and Methadone medicationsactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/buprenorphine-medicationsBuprenorphine Medicationsactive2025-02hl7
fhir.dicomR4ValueSet/allAll DICOM Controlled Terminology Definitionsactive2025-07hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ISBTConvalescentPlasmaCodeVSISBT Convalescent Plasma Codesdraft2023-08hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ISBTBloodProductCodeVSISBT Blood Product Codesdraft2023-08hl7
hl7.fhir.us.registry-protocolsR4ValueSet/SEattleAnginaQsSeattle Angina Questionsactivecic2023-11hl7
fhir.tx.support.r4R4ValueSet/covid-19-obsCOVID-19 related Observation codesdraft2020-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.13Screening and Assessment Survey Codesactive2024-10hl7
fhir.cdc.opioid-cds-r4R4ValueSet/oxycodone-medicationsOxycodone Medicationsactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6053Lab Test Name (Reportable Conditions)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6054Lab Test Result (Reportable Conditions)active2016-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.58Diabetes Medicationsactive2022-03hl7
fhir.tx.support.r4R4ValueSet/covid-19-condCOVID-19 related Condition codesdraft2020-03hl7
hl7.fhir.us.registry-protocolsR4ValueSet/HemodialysisOrPeritonealDialysishemodialysis or peritoneal dialysisactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CardiacArrestCardiac Arrestactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CABGCoronary artery bypass graftingactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CerebrovascularDiseaseCerebrovascular Diseaseactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/PeripheralArterialOcclusiveDiseasePeripheral Arterial Occlusive Diseaseactivecic2023-11hl7